364.30
+5.05(+1.41%)
Currency In INR
| Previous Close | 359.25 |
| Open | 363 |
| Day High | 366.35 |
| Day Low | 359.9 |
| 52-Week High | 406 |
| 52-Week Low | 291 |
| Volume | 2.14M |
| Average Volume | 4.73M |
| Market Cap | 487.05B |
| PE | 113.84 |
| EPS | 3.2 |
| Moving Average 50 Days | 368.22 |
| Moving Average 200 Days | 351.27 |
| Change | 5.05 |
If you invested ₹1000 in Biocon Limited (BIOCON.NS) 10 years ago, it would be worth ₹4,671.71 as of August 18, 2025 at a share price of ₹364.3. Whereas If you bought ₹1000 worth of Biocon Limited (BIOCON.NS) shares 5 years ago, it would be worth ₹930.79 as of August 18, 2025 at a share price of ₹364.3.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
GlobeNewswire Inc.
Jul 15, 2025 7:25 PM GMT
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today annou